Michael J. Fox Foundation is dedicated to finding better treatments and cure for Parkinson’s disease.
Business Model: B2C Non-Profit
Revenue: $163.1M
Employees: 201-500
Address: Grand Central Station
City: New York
State: NY
Zip: 10163
Country: US
The Michael J. Fox Foundation is a trust fund and a nonprofit research firm. It focuses on finding a cure for Parkinson disease and improved therapies for those living with the condition. The firm operates through a funded and targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors, and volunteers. The Michael J. Fox Foundation was founded by Deborah Brooks in 2000 and is headquartered in New York.
Contact Phone:
+18007087644
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2011 | Trevena | Grant | 205k |
8/2022 | Koneksa Health | Grant | - |
11/2010 | Ceregene | Series D | 11.5M |
10/2021 | Sinopia Biosciences | Grant | 2M |
4/2014 | Domain Therapeutics | Grant | 230k |
1/2017 | Addex Therapeutics | Grant | 835k |
1/2020 | Sinopia Biosciences | Grant | 450k |
5/2019 | Casma Therapeutics | Grant | 370k |
5/2022 | Modality.AI, Inc. | Grant | 2.3M |
1/2017 | Neuropore Therapies | Grant | - |
1/2022 | ND BioSciences | Grant | - |
10/2022 | Muna Therapeutics | Grant | 4.9M |
11/2011 | Sapiens Steering Brain Stimulation | Series A | 13.3M |
6/2022 | Koneksa Health | Grant | - |
4/2017 | MISSION Therapeutics | Grant | - |
11/2020 | Caraway Therapeutics | Grant | - |
2/2015 | Saniona | Grant | 590.7k |
7/2022 | EpicentRx Inc | Grant | 0 |
8/2022 | Seelos Therapeutics | Grant | - |
5/2013 | ZelosDx | Grant | 250k |
3/2017 | Inhibikase Therapeutics | Grant | 433k |
6/2022 | Alzprotect | Grant | 338k |
7/2021 | NRG Therapeutics | Grant | 0 |
2/2023 | Newel Health | Grant | 2.5M |
1/2018 | Neuropore Therapies | Grant | - |
10/2021 | MISSION Therapeutics | Grant | 0 |
2/2018 | OccamzRazor | Grant | 650k |
6/2019 | Nitrase Therapeutics | Grant | - |
12/2021 | Arkuda Therapeutics | Grant | - |
3/2020 | Lundbeck | Grant | - |
2/2020 | Olaris | Grant | - |
9/2013 | Motus Therapeutics | Grant | 1.4M |
12/2010 | Amicus Therapeutics | Grant | 500k |
10/2016 | Asceneuron | Grant | - |
5/2012 | Envoy Therapeutics | Grant | 1.2M |
9/2014 | nLife Therapeutics | Grant | 350k |
3/2013 | Addex Therapeutics | Grant | 1M |
7/2022 | ZyVersa Therapeutics | Grant | - |
5/2022 | Asceneuron | Grant | - |
5/2018 | Alkahest | Grant | - |
11/2020 | MapLight Therapeutics | Grant | 8.1M |
11/2022 | Esya | Grant | 452k |
7/2018 | Amydis | Grant | - |
3/2019 | Inflazome | Grant | 1M |
1/2009 | Omeros | Grant | 465k |
10/2022 | Amydis | Grant | 1.5M |
8/2020 | Amydis | Grant | - |
8/2022 | Koneksa Health | Grant | - |
7/2022 | ZyVersa Therapeutics | Grant | - |
7/2022 | EpicentRx Inc | Grant | 0 |
6/2022 | Koneksa Health | Grant | - |
6/2022 | Alzprotect | Grant | 0 |
5/2022 | Asceneuron | Grant | - |
1/2022 | ND BioSciences | Grant | - |
12/2021 | Arkuda Therapeutics | Grant | - |
10/2021 | MISSION Therapeutics | Grant | 0 |
7/2021 | NRG Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|